173 related articles for article (PubMed ID: 34259647)
1. The sodium iodide symporter (NIS): novel applications for radionuclide imaging and treatment.
Spitzweg C; Nelson PJ; Wagner E; Bartenstein P; Weber WA; Schwaiger M; Morris JC
Endocr Relat Cancer; 2021 Sep; 28(10):T193-T213. PubMed ID: 34259647
[TBL] [Abstract][Full Text] [Related]
2. Imaging and targeted therapy of pancreatic ductal adenocarcinoma using the theranostic sodium iodide symporter (NIS) gene.
Schmohl KA; Gupta A; Grünwald GK; Trajkovic-Arsic M; Klutz K; Braren R; Schwaiger M; Nelson PJ; Ogris M; Wagner E; Siveke JT; Spitzweg C
Oncotarget; 2017 May; 8(20):33393-33404. PubMed ID: 28380420
[TBL] [Abstract][Full Text] [Related]
3. Effective control of tumor growth through spatial and temporal control of theranostic sodium iodide symporter (
Tutter M; Schug C; Schmohl KA; Urnauer S; Schwenk N; Petrini M; Lokerse WJM; Zach C; Ziegler S; Bartenstein P; Weber WA; Wagner E; Lindner LH; Nelson PJ; Spitzweg C
Theranostics; 2020; 10(10):4490-4506. PubMed ID: 32292510
[No Abstract] [Full Text] [Related]
4. Mesenchymal Stem Cell-mediated Image-guided Sodium Iodide Symporter (NIS) Gene Therapy Improves Survival of Glioblastoma-bearing Mice.
Kitzberger C; Spellerberg R; Han Y; Schmohl KA; Stauss C; Zach C; Kälin RE; Multhoff G; Eiber M; Schilling F; Glass R; Weber WA; Wagner E; Nelson PJ; Spitzweg C
Clin Cancer Res; 2023 Mar; 29(5):930-942. PubMed ID: 36516189
[TBL] [Abstract][Full Text] [Related]
5. Mesenchymal stem cell-mediated, tumor stroma-targeted radioiodine therapy of metastatic colon cancer using the sodium iodide symporter as theranostic gene.
Knoop K; Schwenk N; Schmohl K; Müller A; Zach C; Cyran C; Carlsen J; Böning G; Bartenstein P; Göke B; Wagner E; Nelson PJ; Spitzweg C
J Nucl Med; 2015 Apr; 56(4):600-6. PubMed ID: 25745085
[TBL] [Abstract][Full Text] [Related]
6. Establishment of radioactive astatine and iodine uptake in cancer cell lines expressing the human sodium/iodide symporter.
Petrich T; Helmeke HJ; Meyer GJ; Knapp WH; Pötter E
Eur J Nucl Med Mol Imaging; 2002 Jul; 29(7):842-54. PubMed ID: 12111124
[TBL] [Abstract][Full Text] [Related]
7. The sodium iodide symporter (NIS) as theranostic gene: its emerging role in new imaging modalities and non-viral gene therapy.
Kitzberger C; Spellerberg R; Morath V; Schwenk N; Schmohl KA; Schug C; Urnauer S; Tutter M; Eiber M; Schilling F; Weber WA; Ziegler S; Bartenstein P; Wagner E; Nelson PJ; Spitzweg C
EJNMMI Res; 2022 May; 12(1):25. PubMed ID: 35503582
[TBL] [Abstract][Full Text] [Related]
8. Systemic image-guided liver cancer radiovirotherapy using dendrimer-coated adenovirus encoding the sodium iodide symporter as theranostic gene.
Grünwald GK; Vetter A; Klutz K; Willhauck MJ; Schwenk N; Senekowitsch-Schmidtke R; Schwaiger M; Zach C; Wagner E; Göke B; Holm PS; Ogris M; Spitzweg C
J Nucl Med; 2013 Aug; 54(8):1450-7. PubMed ID: 23843567
[TBL] [Abstract][Full Text] [Related]
9. Systemic tumor-targeted sodium iodide symporter (NIS) gene therapy of hepatocellular carcinoma mediated by B6 peptide polyplexes.
Urnauer S; Klutz K; Grünwald GK; Morys S; Schwenk N; Zach C; Gildehaus FJ; Rödl W; Ogris M; Wagner E; Spitzweg C
J Gene Med; 2017 May; 19(5):. PubMed ID: 28423213
[TBL] [Abstract][Full Text] [Related]
10. Establishment of a human hepatocellular carcinoma cell line highly expressing sodium iodide symporter for radionuclide gene therapy.
Kang JH; Chung JK; Lee YJ; Shin JH; Jeong JM; Lee DS; Lee MC
J Nucl Med; 2004 Sep; 45(9):1571-6. PubMed ID: 15347726
[TBL] [Abstract][Full Text] [Related]
11. Preclinical efficacy of the oncolytic measles virus expressing the sodium iodide symporter in iodine non-avid anaplastic thyroid cancer: a novel therapeutic agent allowing noninvasive imaging and radioiodine therapy.
Reddi HV; Madde P; McDonough SJ; Trujillo MA; Morris JC; Myers RM; Peng KW; Russell SJ; McIver B; Eberhardt NL
Cancer Gene Ther; 2012 Sep; 19(9):659-65. PubMed ID: 22790962
[TBL] [Abstract][Full Text] [Related]
12. Stromal targeting of sodium iodide symporter using mesenchymal stem cells allows enhanced imaging and therapy of hepatocellular carcinoma.
Knoop K; Schwenk N; Dolp P; Willhauck MJ; Zischek C; Zach C; Hacker M; Göke B; Wagner E; Nelson PJ; Spitzweg C
Hum Gene Ther; 2013 Mar; 24(3):306-16. PubMed ID: 23402366
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo properties of a human anaplastic thyroid carcinoma cell line transfected with the sodium iodide symporter gene.
Lee YJ; Chung JK; Shin JH; Kang JH; Jeong JM; Lee DS; Lee MC
Thyroid; 2004 Nov; 14(11):889-95. PubMed ID: 15671766
[TBL] [Abstract][Full Text] [Related]
14. Treatment of medulloblastoma using an oncolytic measles virus encoding the thyroidal sodium iodide symporter shows enhanced efficacy with radioiodine.
Hutzen B; Pierson CR; Russell SJ; Galanis E; Raffel C; Studebaker AW
BMC Cancer; 2012 Nov; 12():508. PubMed ID: 23134812
[TBL] [Abstract][Full Text] [Related]
15. Reintroducing the Sodium-Iodide Symporter to Anaplastic Thyroid Carcinoma.
Schmohl KA; Dolp P; Schug C; Knoop K; Klutz K; Schwenk N; Bartenstein P; Nelson PJ; Ogris M; Wagner E; Spitzweg C
Thyroid; 2017 Dec; 27(12):1534-1543. PubMed ID: 29032724
[TBL] [Abstract][Full Text] [Related]
16. TGFB1-driven mesenchymal stem cell-mediated NIS gene transfer.
Schug C; Urnauer S; Jaeckel C; Schmohl KA; Tutter M; Steiger K; Schwenk N; Schwaiger M; Wagner E; Nelson PJ; Spitzweg C
Endocr Relat Cancer; 2019 Jan; 26(1):89-101. PubMed ID: 30121623
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia-targeted 131I therapy of hepatocellular cancer after systemic mesenchymal stem cell-mediated sodium iodide symporter gene delivery.
Müller AM; Schmohl KA; Knoop K; Schug C; Urnauer S; Hagenhoff A; Clevert DA; Ingrisch M; Niess H; Carlsen J; Zach C; Wagner E; Bartenstein P; Nelson PJ; Spitzweg C
Oncotarget; 2016 Aug; 7(34):54795-54810. PubMed ID: 27458162
[TBL] [Abstract][Full Text] [Related]
18. Approaches to gene therapy with sodium/iodide symporter.
Spitzweg C; Morris JC
Exp Clin Endocrinol Diabetes; 2001; 109(1):56-9. PubMed ID: 11573142
[TBL] [Abstract][Full Text] [Related]
19. Image-guided, tumor stroma-targeted 131I therapy of hepatocellular cancer after systemic mesenchymal stem cell-mediated NIS gene delivery.
Knoop K; Kolokythas M; Klutz K; Willhauck MJ; Wunderlich N; Draganovici D; Zach C; Gildehaus FJ; Böning G; Göke B; Wagner E; Nelson PJ; Spitzweg C
Mol Ther; 2011 Sep; 19(9):1704-13. PubMed ID: 21587211
[TBL] [Abstract][Full Text] [Related]
20. Targeted radioiodine therapy of neuroblastoma tumors following systemic nonviral delivery of the sodium iodide symporter gene.
Klutz K; Russ V; Willhauck MJ; Wunderlich N; Zach C; Gildehaus FJ; Göke B; Wagner E; Ogris M; Spitzweg C
Clin Cancer Res; 2009 Oct; 15(19):6079-86. PubMed ID: 19789324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]